 |
|
|
| |
Preclinical Profiling of ABI-6250, a Novel Orally Bioavailable Small-Molecule Therapeutic Candidate for the Treatment of Chronic Hepatitis
|
| |
| |
European Association for the Study of the Liver (EASL) - The International Liver Congress 2024, June 5-8, 2024
Marc P Windisch, Nuruddin Unchwaniwala, Jinghu Carl Li, Yanhong Zhu, Heidi Contreras, Dinara Azimova, Francielle Tramontini Gomes de Sousa, Joseph Tan, Kirsten Stray, Ariel Tang, Peter Haggie, Gene Schulze, Michael Shen, Jiaxin Yu, Michel Perron, Michael A Walker, William E Delaney, Min Zhong
Assembly Biosciences, Inc., South San Francisco, CA, USA
|
| |
|
|
|
|
|
